Kineta, Inc.
🇺🇸United States
Clinical Trials
4
Active:0
Completed:3
Trial Phases
1 Phases
Phase 1:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (100.0%)A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Phase 1
Recruiting
- Conditions
- CancerSolid TumorKidney CancerMelanomaCarcinomaPancreatic CancerColo-rectal CancerGastric CancerEsophageal CancerOvarian Cancer
- Interventions
- Drug: KVA12123 - Dose ExpansionDrug: KVA12123 - Dose Escalation
- First Posted Date
- 2023-02-01
- Last Posted Date
- 2023-07-13
- Lead Sponsor
- Kineta Inc.
- Target Recruit Count
- 314
- Registration Number
- NCT05708950
- Locations
- 🇺🇸
UCLA Health (Santa Monica Cancer Care), Santa Monica, California, United States
🇺🇸Sarah Cannon Research Institute at HealthONE, Denver, Colorado, United States
🇺🇸Sarah Cannon Research Institute at Florida Cancer Specialists, Sarasota, Florida, United States
Multiple Ascending Oral Dose 14-Day Trial of LHF-535 in Healthy Participants
- First Posted Date
- 2019-06-21
- Last Posted Date
- 2020-07-09
- Lead Sponsor
- Kineta Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT03993704
- Locations
- 🇦🇺
Centre for Clinical Studies, Melbourne, Australia
Multiple Ascending Dose Safety Study of ShK-186 (Dalazatide) in Healthy Volunteers
- First Posted Date
- 2015-05-18
- Last Posted Date
- 2015-05-18
- Lead Sponsor
- Kineta Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT02446340
- Locations
- 🇺🇸
PRA International, Lenexa, Kansas, United States
A 4 Week Study of the Safety, Tolerability, and Pharmacodynamics of ShK-186 (Dalazatide) in Active Plaque Psoriasis
- First Posted Date
- 2015-05-06
- Last Posted Date
- 2015-05-06
- Lead Sponsor
- Kineta Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT02435342
- Locations
- 🇨🇦
Innovaderm Research, Inc, Montreal, Quebec, Canada
News
No news found